Bibliography: library/10665-97885
The reference for library/10665-97885 (who-iris) and any references extracted from it. library · All references.
Export these 101 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD
✍ + Add reference (standalone node)
101 shown
-
Mclean, Huong Q; Hickman, C. J; Seward, Jane F; et al. (2010). The immunological basis for immunization series: module 16: mumps. World Health Organization.
10665-97885· catalogue · link · repository record · ISBN 9789241500661 · source:catalogue/records/10665-97885.dc.json· held:library/10665-97885
export: BibTeX · RIS · CSL-JSON · DC XML -
Jeryl Lynn/RIT 4385 (Fescharek et al., 1990) ~5 500 000 Drug side-effect surveillance 0.1 (Schlipkoter et al., 2002) 1 575 936 National hospital surveillance system <0.2 (Miller et al., 2007) >99 000 (Black et al., 1997)
· extracted · source:references/10665-97885.sec-006.1.jsonJeryl Lynn/RIT 4385 (Fescharek et al., 1990) ~5 500 000 Drug side-effect surveillance 0.1 (Schlipkoter et al., 2002) 1 575 936 National hospital surveillance system <0.2 (Miller et al., 2007) >99 000 (Black et al., 1997)
- Issued
- 1997
- Type
- document
- As printed
- Jeryl Lynn/RIT 4385 (Fescharek et al., 1990) ~5 500 000 Drug side-effect surveillance 0.1 (Schlipkoter et al., 2002) 1 575 936 National hospital surveillance system <0.2 (Miller et al., 2007) >99 000 (Black et al., 1997)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.1 - provenance: extracted
- read from
references/10665-97885.sec-006.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
United States ~300 000 Urabe Am 9 (Al-Mazrou et al., 2002)
· extracted · source:references/10665-97885.sec-006.2.jsonUnited States ~300 000 Urabe Am 9 (Al-Mazrou et al., 2002)
- Issued
- 2002
- Type
- document
- As printed
- United States ~300 000 Urabe Am 9 (Al-Mazrou et al., 2002)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.2 - provenance: extracted
- read from
references/10665-97885.sec-006.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Saudi Arabia 2 412 078 6–13 years* National, hospital, and school surveillance 0.3 (Jonville-Bera et al., 1996) 11 months – 10 years Reports to regional pharmacovigilance centres or manufacturer 0.82 0.77– 0.92)
· extracted · source:references/10665-97885.sec-006.3.jsonSaudi Arabia 2 412 078 6–13 years* National, hospital, and school surveillance 0.3 (Jonville-Bera et al., 1996) 11 months – 10 years Reports to regional pharmacovigilance centres or manufacturer 0.82 0.77– 0.92)
- Issued
- 1996
- Type
- document
- As printed
- Saudi Arabia 2 412 078 6–13 years* National, hospital, and school surveillance 0.3 (Jonville-Bera et al., 1996) 11 months – 10 years Reports to regional pharmacovigilance centres or manufacturer 0.82 0.77– 0.92)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.3 - provenance: extracted
- read from
references/10665-97885.sec-006.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Canada 250 000-300 000 Laboratory reports 1.6 (Rebiere & Galy-Eyraud, 1995) 3 290 470 (mostly <24 months)
· extracted · source:references/10665-97885.sec-006.5.jsonCanada 250 000-300 000 Laboratory reports 1.6 (Rebiere & Galy-Eyraud, 1995) 3 290 470 (mostly <24 months)
- Issued
- 1995
- Type
- document
- As printed
- Canada 250 000-300 000 Laboratory reports 1.6 (Rebiere & Galy-Eyraud, 1995) 3 290 470 (mostly <24 months)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.5 - provenance: extracted
- read from
references/10665-97885.sec-006.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Vaccine manufacturer’s surveillance system and laboratory surveillance 3.5 1.5–5.6) (Farrington et al., 1995)
· extracted · source:references/10665-97885.sec-006.6.jsonVaccine manufacturer’s surveillance system and laboratory surveillance 3.5 1.5–5.6) (Farrington et al., 1995)
- Issued
- 1995
- Type
- document
- As printed
- Vaccine manufacturer’s surveillance system and laboratory surveillance 3.5 1.5–5.6) (Farrington et al., 1995)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.6 - provenance: extracted
- read from
references/10665-97885.sec-006.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
England 77 200 6.7 (Dourado et al., 2000) 452 344 State surveillance and prospective hospital admission following mass-vaccination campaign 7.1 (Miller et al., 2007) 49 585 8.0 2.2–21)
· extracted · source:references/10665-97885.sec-006.7.jsonEngland 77 200 6.7 (Dourado et al., 2000) 452 344 State surveillance and prospective hospital admission following mass-vaccination campaign 7.1 (Miller et al., 2007) 49 585 8.0 2.2–21)
- Issued
- 2007
- Type
- document
- As printed
- England 77 200 6.7 (Dourado et al., 2000) 452 344 State surveillance and prospective hospital admission following mass-vaccination campaign 7.1 (Miller et al., 2007) 49 585 8.0 2.2–21)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.7 - provenance: extracted
- read from
references/10665-97885.sec-006.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
(Sugiura & Yamada, 1991) 630 157 Passive surveillance to Ministry of Health 12–15 (Miller et al., 1993) 78 300 Public Health Laboratories and hospital discharge diagnosis (Colville & Pugh, 1992) 22 817 Laboratory records 5.3–47)
· extracted · source:references/10665-97885.sec-006.8.json(Sugiura & Yamada, 1991) 630 157 Passive surveillance to Ministry of Health 12–15 (Miller et al., 1993) 78 300 Public Health Laboratories and hospital discharge diagnosis (Colville & Pugh, 1992) 22 817 Laboratory records 5.3–47)
- Issued
- 1992
- Type
- document
- As printed
- (Sugiura & Yamada, 1991) 630 157 Passive surveillance to Ministry of Health 12–15 (Miller et al., 1993) 78 300 Public Health Laboratories and hospital discharge diagnosis (Colville & Pugh, 1992) 22 817 Laboratory records 5.3–47)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.8 - provenance: extracted
- read from
references/10665-97885.sec-006.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
(Fujinaga et al., 1991) 11 750 Hospital surveillance (Ueda et al., 1995)
· extracted · source:references/10665-97885.sec-006.9.json(Fujinaga et al., 1991) 11 750 Hospital surveillance (Ueda et al., 1995)
- Issued
- 1995
- Type
- document
- As printed
- (Fujinaga et al., 1991) 11 750 Hospital surveillance (Ueda et al., 1995)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.9 - provenance: extracted
- read from
references/10665-97885.sec-006.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Leningrad 3 (Cizman et al., 1989)
· extracted · source:references/10665-97885.sec-006.10.jsonLeningrad 3 (Cizman et al., 1989)
- Issued
- 1989
- Type
- document
- As printed
- Leningrad 3 (Cizman et al., 1989)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.10 - provenance: extracted
- read from
references/10665-97885.sec-006.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Yugoslavia 115 253 L-Zagreb (Pan American Health Organization, 1999)
· extracted · source:references/10665-97885.sec-006.11.jsonYugoslavia 115 253 L-Zagreb (Pan American Health Organization, 1999)
- Issued
- 1999
- Type
- document
- As printed
- Yugoslavia 115 253 L-Zagreb (Pan American Health Organization, 1999)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.11 - provenance: extracted
- read from
references/10665-97885.sec-006.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Bahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
· extracted · source:references/10665-97885.sec-006.12.jsonBahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
- Issued
- 2004
- Type
- document
- As printed
- Bahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.12 - provenance: extracted
- read from
references/10665-97885.sec-006.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
India 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
· extracted · source:references/10665-97885.sec-006.13.jsonIndia 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
- Issued
- 2006
- Type
- document
- As printed
- India 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.13 - provenance: extracted
- read from
references/10665-97885.sec-006.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
(Tesovic et al., 1993) 10 months–6 years 64–116)
· extracted · source:references/10665-97885.sec-006.14.json(Tesovic et al., 1993) 10 months–6 years 64–116)
- Issued
- 1993
- Type
- document
- As printed
- (Tesovic et al., 1993) 10 months–6 years 64–116)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.14 - provenance: extracted
- read from
references/10665-97885.sec-006.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Hoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
· extracted · source:references/10665-97885.sec-006.17.jsonHoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
- Issued
- 1995
- Type
- document
- As printed
- Hoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006.17 - provenance: extracted
- read from
references/10665-97885.sec-006.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
L-Zagreb (Pan American Health Organization, 1999)
· extracted · source:references/10665-97885.sec-006-2.1.jsonL-Zagreb (Pan American Health Organization, 1999)
- Issued
- 1999
- Type
- document
- As printed
- L-Zagreb (Pan American Health Organization, 1999)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006-2.1 - provenance: extracted
- read from
references/10665-97885.sec-006-2.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Bahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
· extracted · source:references/10665-97885.sec-006-2.2.jsonBahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
- Issued
- 2004
- Type
- document
- As printed
- Bahamas >100 000 4–40 years Surveillance activities not mentioned (note: small proportion of doses were Jeryl Lynn mumps strain) 0.96 (Phadke et al., 2004)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006-2.2 - provenance: extracted
- read from
references/10665-97885.sec-006-2.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
India 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
· extracted · source:references/10665-97885.sec-006-2.3.jsonIndia 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
- Issued
- 2006
- Type
- document
- As printed
- India 190 723 Post-marketing surveillance surveys to paediatricians (note: response rate 68%) 1.0 (da Cunha et al., 2002) 845 889 Children† Routine surveillance system and hospital records 5.2–16 (Arruda & Kondageski, 2001) 590 609 2–39 years National surveillance (da Silveira et al., 2002) 110 629 Passive surveillance (Dos Santos et al., 2002) 2 226 6–12 years Active follow-up (Tesovic & Lesnikar, 2006) 96 994 12–46 months Prospective hospital study 36–66)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006-2.3 - provenance: extracted
- read from
references/10665-97885.sec-006-2.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
(Tesovic et al., 1993) 10 months–6 years 64–116)
· extracted · source:references/10665-97885.sec-006-2.4.json(Tesovic et al., 1993) 10 months–6 years 64–116)
- Issued
- 1993
- Type
- document
- As printed
- (Tesovic et al., 1993) 10 months–6 years 64–116)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006-2.4 - provenance: extracted
- read from
references/10665-97885.sec-006-2.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Hoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
· extracted · source:references/10665-97885.sec-006-2.7.jsonHoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
- Issued
- 1995
- Type
- document
- As printed
- Hoshino (Kimura et al., 1996) 21 717 (Ueda et al., 1995) * Probable second dose. † Campaign dose, irrespective of prior vaccination history.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-006-2.7 - provenance: extracted
- read from
references/10665-97885.sec-006-2.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-006-13-mumps-vaccines.md
-
Median Range 95.9 74.2, 99.6 (Weibel et al., 1967; Hilleman et al., 1968; Sugg et al., 1968; Brunell et al., 1969; Vesikari et al., 1983b; Fedova et al., 1987) 90.0 83.5, 90.6 (Weibel et al., 1973; Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 89, 97 (Borgono et al., 1973; Ehrenkranz et al., 1975; Schwarz et al., 1975; Lerman et al., 1981; Popow-Kraupp et al., 1986; Schwarzer et al., 1998; Usonis et al., 1998; Usonis et al., 1999; Klinge et al., 2000; Redd et al., 2004; Feiterna-Sperling et al., 2005) tetravalent 99.5 98, 100 (Watson et al., 1996; Shinefield et al., 2005; Kuter et al., 2006; Bernstein et al., 2007)
· extracted · source:references/10665-97885.sec-013.1.jsonMedian Range 95.9 74.2, 99.6 (Weibel et al., 1967; Hilleman et al., 1968; Sugg et al., 1968; Brunell et al., 1969; Vesikari et al., 1983b; Fedova et al., 1987) 90.0 83.5, 90.6 (Weibel et al., 1973; Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 89, 97 (Borgono et al., 1973; Ehrenkranz et al., 1975; Schwarz et al., 1975; Lerman et al., 1981; Popow-Kraupp et al., 1986; Schwarzer et al., 1998; Usonis et al., 1998; Usonis et al., 1999; Klinge et al., 2000; Redd et al., 2004; Feiterna-Sperling et al., 2005) tetravalent 99.5 98, 100 (Watson et al., 1996; Shinefield et al., 2005; Kuter et al., 2006; Bernstein et al., 2007)
- Issued
- 2007
- Type
- document
- As printed
- Median Range 95.9 74.2, 99.6 (Weibel et al., 1967; Hilleman et al., 1968; Sugg et al., 1968; Brunell et al., 1969; Vesikari et al., 1983b; Fedova et al., 1987) 90.0 83.5, 90.6 (Weibel et al., 1973; Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 89, 97 (Borgono et al., 1973; Ehrenkranz et al., 1975; Schwarz et al., 1975; Lerman et al., 1981; Popow-Kraupp et al., 1986; Schwarzer et al., 1998; Usonis et al., 1998; Usonis et al., 1999; Klinge et al., 2000; Redd et al., 2004; Feiterna-Sperling et al., 2005) tetravalent 99.5 98, 100 (Watson et al., 1996; Shinefield et al., 2005; Kuter et al., 2006; Bernstein et al., 2007)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.1 - provenance: extracted
- read from
references/10665-97885.sec-013.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
RIT 4385, 96.4 88, 98.6 (Usonis et al., 1998; Gatchalian et al., 1999; Usonis et al., 1999; Crovari et al., 2000; Lee et al., 2002; Nolan et al., 2002; Stuck et al., 2002; Lim et al., 2007) 94.8 82.6, 97 (Isomura et al., 1973; Ehrengut et al., 1983; Vesikari et al., 1983b) 84.2 78.7, 96.9 (Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 96.9, 100 (Berger et al., 1988; Robertson et al., 1988; Dunlop et al., 1989; Schoub et al., 1990; Forleo-Neto et al., 1997)
· extracted · source:references/10665-97885.sec-013.2.jsonRIT 4385, 96.4 88, 98.6 (Usonis et al., 1998; Gatchalian et al., 1999; Usonis et al., 1999; Crovari et al., 2000; Lee et al., 2002; Nolan et al., 2002; Stuck et al., 2002; Lim et al., 2007) 94.8 82.6, 97 (Isomura et al., 1973; Ehrengut et al., 1983; Vesikari et al., 1983b) 84.2 78.7, 96.9 (Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 96.9, 100 (Berger et al., 1988; Robertson et al., 1988; Dunlop et al., 1989; Schoub et al., 1990; Forleo-Neto et al., 1997)
- Issued
- 1997
- Type
- document
- As printed
- RIT 4385, 96.4 88, 98.6 (Usonis et al., 1998; Gatchalian et al., 1999; Usonis et al., 1999; Crovari et al., 2000; Lee et al., 2002; Nolan et al., 2002; Stuck et al., 2002; Lim et al., 2007) 94.8 82.6, 97 (Isomura et al., 1973; Ehrengut et al., 1983; Vesikari et al., 1983b) 84.2 78.7, 96.9 (Vesikari et al., 1983a; Popow-Kraupp et al., 1986) 96.9, 100 (Berger et al., 1988; Robertson et al., 1988; Dunlop et al., 1989; Schoub et al., 1990; Forleo-Neto et al., 1997)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.2 - provenance: extracted
- read from
references/10665-97885.sec-013.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Rubini 93.3 23.3, 95 (Gluck et al., 1986; Just et al., 1986; Berger et al., 1988; Schwarzer et al., 1998; Khalil et al., 1999; Crovari et al., 2000)
· extracted · source:references/10665-97885.sec-013.3.jsonRubini 93.3 23.3, 95 (Gluck et al., 1986; Just et al., 1986; Berger et al., 1988; Schwarzer et al., 1998; Khalil et al., 1999; Crovari et al., 2000)
- Issued
- 2000
- Type
- document
- As printed
- Rubini 93.3 23.3, 95 (Gluck et al., 1986; Just et al., 1986; Berger et al., 1988; Schwarzer et al., 1998; Khalil et al., 1999; Crovari et al., 2000)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.3 - provenance: extracted
- read from
references/10665-97885.sec-013.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Leningrad-3 93.5 89, 98 (Smorodintsev et al., 1970)
· extracted · source:references/10665-97885.sec-013.4.jsonLeningrad-3 93.5 89, 98 (Smorodintsev et al., 1970)
- Issued
- 1970
- Type
- document
- As printed
- Leningrad-3 93.5 89, 98 (Smorodintsev et al., 1970)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.4 - provenance: extracted
- read from
references/10665-97885.sec-013.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Leningrad-Zagreb 89.4 88.1, 90.7 (Beck et al., 1989)
· extracted · source:references/10665-97885.sec-013.5.jsonLeningrad-Zagreb 89.4 88.1, 90.7 (Beck et al., 1989)
- Issued
- 1989
- Type
- document
- As printed
- Leningrad-Zagreb 89.4 88.1, 90.7 (Beck et al., 1989)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.5 - provenance: extracted
- read from
references/10665-97885.sec-013.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
BBM-18 84.8 (Feiterna-Sperling et al., 2005)
· extracted · source:references/10665-97885.sec-013.6.jsonBBM-18 84.8 (Feiterna-Sperling et al., 2005)
- Issued
- 2005
- Type
- document
- As printed
- BBM-18 84.8 (Feiterna-Sperling et al., 2005)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.6 - provenance: extracted
- read from
references/10665-97885.sec-013.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Sofia 6 93.4 92.6, 94.1 (Odisseev & Gacheva, 1994)
· extracted · source:references/10665-97885.sec-013.7.jsonSofia 6 93.4 92.6, 94.1 (Odisseev & Gacheva, 1994)
- Issued
- 1994
- Type
- document
- As printed
- Sofia 6 93.4 92.6, 94.1 (Odisseev & Gacheva, 1994)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.7 - provenance: extracted
- read from
references/10665-97885.sec-013.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Hoshino 98.4 96.8, 100 (Makino et al., 1990)
· extracted · source:references/10665-97885.sec-013.8.jsonHoshino 98.4 96.8, 100 (Makino et al., 1990)
- Issued
- 1990
- Type
- document
- As printed
- Hoshino 98.4 96.8, 100 (Makino et al., 1990)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.8 - provenance: extracted
- read from
references/10665-97885.sec-013.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
S-12 (Sassani et al., 1991) 3.2 Immune responses to revaccination Studies have examined presence of antibodies prior to and following the second dose of mumps vaccine. In a prospective study, <1% of subjects were seronegative before a second dose of mumps vaccine and, following the second dose, IgM was detectable in only 2% of individuals, suggesting that most vaccine recipients had mounted a secondary immune response to revaccination (LeBaron et al., 2009). Although up to 30% of individuals were reported to be seronegative prior to revaccination in other studies, 75% to 97% seroconverted following the second dose of mumps vaccine.
· extracted · source:references/10665-97885.sec-013.9.jsonS-12 (Sassani et al., 1991) 3.2 Immune responses to revaccination Studies have examined presence of antibodies prior to and following the second dose of mumps vaccine. In a prospective study, <1% of subjects were seronegative before a second dose of mumps vaccine and, following the second dose, IgM was detectable in only 2% of individuals, suggesting that most vaccine recipients had mounted a secondary immune response to revaccination (LeBaron et al., 2009). Although up to 30% of individuals were reported to be seronegative prior to revaccination in other studies, 75% to 97% seroconverted following the second dose of mumps vaccine.
- Issued
- 2009
- Type
- document
- As printed
- S-12 (Sassani et al., 1991) 3.2 Immune responses to revaccination Studies have examined presence of antibodies prior to and following the second dose of mumps vaccine. In a prospective study, <1% of subjects were seronegative before a second dose of mumps vaccine and, following the second dose, IgM was detectable in only 2% of individuals, suggesting that most vaccine recipients had mounted a secondary immune response to revaccination (LeBaron et al., 2009). Although up to 30% of individuals were reported to be seronegative prior to revaccination in other studies, 75% to 97% seroconverted following the second dose of mumps vaccine.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.9 - provenance: extracted
- read from
references/10665-97885.sec-013.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
There was no assessment to determine if seronegativity was due to primary vaccine failure, or having antibody below the level of test detection (Broliden et al., 1998; Gothefors et al., 2001).
· extracted · source:references/10665-97885.sec-013.10.jsonThere was no assessment to determine if seronegativity was due to primary vaccine failure, or having antibody below the level of test detection (Broliden et al., 1998; Gothefors et al., 2001).
- Issued
- 2001
- Type
- document
- As printed
- There was no assessment to determine if seronegativity was due to primary vaccine failure, or having antibody below the level of test detection (Broliden et al., 1998; Gothefors et al., 2001).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.10 - provenance: extracted
- read from
references/10665-97885.sec-013.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Among individuals with neutralizing antibodies prior to receipt of a second dose, an increase in antibody levels generally occurred following revaccination. More than 50% of those revaccinated had a four-fold increase in antibody titres (LeBaron et al., 2009). In addition, the proportion of individuals with low titres was significantly reduced.
· extracted · source:references/10665-97885.sec-013.11.jsonAmong individuals with neutralizing antibodies prior to receipt of a second dose, an increase in antibody levels generally occurred following revaccination. More than 50% of those revaccinated had a four-fold increase in antibody titres (LeBaron et al., 2009). In addition, the proportion of individuals with low titres was significantly reduced.
- Issued
- 2009
- Type
- document
- As printed
- Among individuals with neutralizing antibodies prior to receipt of a second dose, an increase in antibody levels generally occurred following revaccination. More than 50% of those revaccinated had a four-fold increase in antibody titres (LeBaron et al., 2009). In addition, the proportion of individuals with low titres was significantly reduced.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-013.11 - provenance: extracted
- read from
references/10665-97885.sec-013.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-013-31-antibody-response-following-vaccination.md
-
Country Years after vaccination Number seropositive/Number tested (%) Serological method used 1 dose (LeBaron et al., 2009) 304/308 (99)
· extracted · source:references/10665-97885.sec-015.1.jsonCountry Years after vaccination Number seropositive/Number tested (%) Serological method used 1 dose (LeBaron et al., 2009) 304/308 (99)
- Issued
- 2009
- Type
- document
- As printed
- Country Years after vaccination Number seropositive/Number tested (%) Serological method used 1 dose (LeBaron et al., 2009) 304/308 (99)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.1 - provenance: extracted
- read from
references/10665-97885.sec-015.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
(Gothefors et al., 2001) ~10 230/299 (70)
· extracted · source:references/10665-97885.sec-015.2.json(Gothefors et al., 2001) ~10 230/299 (70)
- Issued
- 2001
- Type
- document
- As printed
- (Gothefors et al., 2001) ~10 230/299 (70)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.2 - provenance: extracted
- read from
references/10665-97885.sec-015.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
(Broliden et al., 1998) ~11 167/229 (73)
· extracted · source:references/10665-97885.sec-015.3.json(Broliden et al., 1998) ~11 167/229 (73)
- Issued
- 1998
- Type
- document
- As printed
- (Broliden et al., 1998) ~11 167/229 (73)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.3 - provenance: extracted
- read from
references/10665-97885.sec-015.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
Neutralizing antibodies 2 doses (LeBaron et al., 2009) 17/189 (91)
· extracted · source:references/10665-97885.sec-015.4.jsonNeutralizing antibodies 2 doses (LeBaron et al., 2009) 17/189 (91)
- Issued
- 2009
- Type
- document
- As printed
- Neutralizing antibodies 2 doses (LeBaron et al., 2009) 17/189 (91)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.4 - provenance: extracted
- read from
references/10665-97885.sec-015.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
(Date et al., 2008) ≥11 134/146 (92)
· extracted · source:references/10665-97885.sec-015.5.json(Date et al., 2008) ≥11 134/146 (92)
- Issued
- 2008
- Type
- document
- As printed
- (Date et al., 2008) ≥11 134/146 (92)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.5 - provenance: extracted
- read from
references/10665-97885.sec-015.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
(LeBaron et al., 2009) 146/154 (95)* (Davidkin et al., 2008)
· extracted · source:references/10665-97885.sec-015.6.json(LeBaron et al., 2009) 146/154 (95)* (Davidkin et al., 2008)
- Issued
- 2008
- Type
- document
- As printed
- (LeBaron et al., 2009) 146/154 (95)* (Davidkin et al., 2008)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.6 - provenance: extracted
- read from
references/10665-97885.sec-015.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
Finland 67/90 (74) * All subjects were seropositive prior to receipt of second mumps vaccine. The immunological basis for immunization series - Module 16: Mumps In two-dose recipients, mumps antibodies were detectable in 95% and 74% of children 12 and 15 years after receipt of a second dose of MMR, respectively, but antibody levels declined with time (Table 3) (Davidkin et al., 2008; LeBaron et al., 2009).
· extracted · source:references/10665-97885.sec-015.7.jsonFinland 67/90 (74) * All subjects were seropositive prior to receipt of second mumps vaccine. The immunological basis for immunization series - Module 16: Mumps In two-dose recipients, mumps antibodies were detectable in 95% and 74% of children 12 and 15 years after receipt of a second dose of MMR, respectively, but antibody levels declined with time (Table 3) (Davidkin et al., 2008; LeBaron et al., 2009).
- Issued
- 2009
- Type
- document
- As printed
- Finland 67/90 (74) * All subjects were seropositive prior to receipt of second mumps vaccine. The immunological basis for immunization series - Module 16: Mumps In two-dose recipients, mumps antibodies were detectable in 95% and 74% of children 12 and 15 years after receipt of a second dose of MMR, respectively, but antibody levels declined with time (Table 3) (Davidkin et al., 2008; LeBaron et al., 2009).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.7 - provenance: extracted
- read from
references/10665-97885.sec-015.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
The significance and function of mumps-specific CMI in protection against mumps disease has yet to be determined. Finally, the role of external boosting from exposure to wild mumps virus in maintaining immunity has not been studied.
· extracted · source:references/10665-97885.sec-015.9.jsonThe significance and function of mumps-specific CMI in protection against mumps disease has yet to be determined. Finally, the role of external boosting from exposure to wild mumps virus in maintaining immunity has not been studied.
- Type
- document
- As printed
- The significance and function of mumps-specific CMI in protection against mumps disease has yet to be determined. Finally, the role of external boosting from exposure to wild mumps virus in maintaining immunity has not been studied.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-015.9 - provenance: extracted
- read from
references/10665-97885.sec-015.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-015-34-duration-of-immunity-to-mumps-vaccination.md
-
Jeryl Lynn — one dose (Chamot et al., 1998) 62 (95% CI: 0, 85)
· extracted · source:references/10665-97885.sec-023.1.jsonJeryl Lynn — one dose (Chamot et al., 1998) 62 (95% CI: 0, 85)
- Issued
- 1998
- Type
- document
- As printed
- Jeryl Lynn — one dose (Chamot et al., 1998) 62 (95% CI: 0, 85)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.1 - provenance: extracted
- read from
references/10665-97885.sec-023.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Harling et al., 2005) 64 (95% CI: 40, 78)
· extracted · source:references/10665-97885.sec-023.2.json(Harling et al., 2005) 64 (95% CI: 40, 78)
- Issued
- 2005
- Type
- document
- As printed
- (Harling et al., 2005) 64 (95% CI: 40, 78)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.2 - provenance: extracted
- read from
references/10665-97885.sec-023.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Toscani et al., 1996) 65 (95% CI: 11, 86)
· extracted · source:references/10665-97885.sec-023.3.json(Toscani et al., 1996) 65 (95% CI: 11, 86)
- Issued
- 1996
- Type
- document
- As printed
- (Toscani et al., 1996) 65 (95% CI: 11, 86)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.3 - provenance: extracted
- read from
references/10665-97885.sec-023.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Castilla et al., 2009) 66 (95% CI: 25, 85)
· extracted · source:references/10665-97885.sec-023.5.json(Castilla et al., 2009) 66 (95% CI: 25, 85)
- Issued
- 2009
- Type
- document
- As printed
- (Castilla et al., 2009) 66 (95% CI: 25, 85)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.5 - provenance: extracted
- read from
references/10665-97885.sec-023.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Population (young children) 70 (95% CI: 50, 80) (Lewis et al., 1979)
· extracted · source:references/10665-97885.sec-023.7.jsonPopulation (young children) 70 (95% CI: 50, 80) (Lewis et al., 1979)
- Issued
- 1979
- Type
- document
- As printed
- Population (young children) 70 (95% CI: 50, 80) (Lewis et al., 1979)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.7 - provenance: extracted
- read from
references/10665-97885.sec-023.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Canada (Wharton et al., 1988) 78 (95% CI: 65, 86)
· extracted · source:references/10665-97885.sec-023.8.jsonCanada (Wharton et al., 1988) 78 (95% CI: 65, 86)
- Issued
- 1988
- Type
- document
- As printed
- Canada (Wharton et al., 1988) 78 (95% CI: 65, 86)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.8 - provenance: extracted
- read from
references/10665-97885.sec-023.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Schlegel et al., 1999) 78 (95% CI: 64, 82)
· extracted · source:references/10665-97885.sec-023.9.json(Schlegel et al., 1999) 78 (95% CI: 64, 82)
- Issued
- 1999
- Type
- document
- As printed
- (Schlegel et al., 1999) 78 (95% CI: 64, 82)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.9 - provenance: extracted
- read from
references/10665-97885.sec-023.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
United States Camp attendees and staff 80 (95% CI: 42, 93) (Sullivan et al., 1985) 81 (95% CI: 71, 88)
· extracted · source:references/10665-97885.sec-023.11.jsonUnited States Camp attendees and staff 80 (95% CI: 42, 93) (Sullivan et al., 1985) 81 (95% CI: 71, 88)
- Issued
- 1985
- Type
- document
- As printed
- United States Camp attendees and staff 80 (95% CI: 42, 93) (Sullivan et al., 1985) 81 (95% CI: 71, 88)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.11 - provenance: extracted
- read from
references/10665-97885.sec-023.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Child care centre and school 81 (95% CI: 58, 91) (Cheek et al., 1995) 82 (95% CI: 77, 86)
· extracted · source:references/10665-97885.sec-023.13.jsonChild care centre and school 81 (95% CI: 58, 91) (Cheek et al., 1995) 82 (95% CI: 77, 86)
- Issued
- 1995
- Type
- document
- As printed
- Child care centre and school 81 (95% CI: 58, 91) (Cheek et al., 1995) 82 (95% CI: 77, 86)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.13 - provenance: extracted
- read from
references/10665-97885.sec-023.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Marin et al., 2008) 82 (95% CI: 0, 98)
· extracted · source:references/10665-97885.sec-023.14.json(Marin et al., 2008) 82 (95% CI: 0, 98)
- Issued
- 2008
- Type
- document
- As printed
- (Marin et al., 2008) 82 (95% CI: 0, 98)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.14 - provenance: extracted
- read from
references/10665-97885.sec-023.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Hersh et al., 1991) 83 (95% CI: 57, 94)
· extracted · source:references/10665-97885.sec-023.15.json(Hersh et al., 1991) 83 (95% CI: 57, 94)
- Issued
- 1991
- Type
- document
- As printed
- (Hersh et al., 1991) 83 (95% CI: 57, 94)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.15 - provenance: extracted
- read from
references/10665-97885.sec-023.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Kim-Farley et al., 1985) 85 (95% CI: 39, 94)
· extracted · source:references/10665-97885.sec-023.16.json(Kim-Farley et al., 1985) 85 (95% CI: 39, 94)
- Issued
- 1985
- Type
- document
- As printed
- (Kim-Farley et al., 1985) 85 (95% CI: 39, 94)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.16 - provenance: extracted
- read from
references/10665-97885.sec-023.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Cohen et al., 2007)* 88 (95% CI: 83, 91)
· extracted · source:references/10665-97885.sec-023.17.json(Cohen et al., 2007)* 88 (95% CI: 83, 91)
- Issued
- 2007
- Type
- document
- As printed
- (Cohen et al., 2007)* 88 (95% CI: 83, 91)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.17 - provenance: extracted
- read from
references/10665-97885.sec-023.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Chaiken et al., 1987) 91 (95% CI: 77, 93)
· extracted · source:references/10665-97885.sec-023.18.json(Chaiken et al., 1987) 91 (95% CI: 77, 93)
- Issued
- 1987
- Type
- document
- As printed
- (Chaiken et al., 1987) 91 (95% CI: 77, 93)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.18 - provenance: extracted
- read from
references/10665-97885.sec-023.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Jeryl Lynn — two doses (Marin et al., 2008) 79 (95% CI: 0, 97)
· extracted · source:references/10665-97885.sec-023.19.jsonJeryl Lynn — two doses (Marin et al., 2008) 79 (95% CI: 0, 97)
- Issued
- 2008
- Type
- document
- As printed
- Jeryl Lynn — two doses (Marin et al., 2008) 79 (95% CI: 0, 97)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.19 - provenance: extracted
- read from
references/10665-97885.sec-023.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Castilla et al., 2009) 83 (95% CI: 54, 94)
· extracted · source:references/10665-97885.sec-023.20.json(Castilla et al., 2009) 83 (95% CI: 54, 94)
- Issued
- 2009
- Type
- document
- As printed
- (Castilla et al., 2009) 83 (95% CI: 54, 94)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.20 - provenance: extracted
- read from
references/10665-97885.sec-023.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Harling et al., 2005)* 88 (95% CI: 62, 96)
· extracted · source:references/10665-97885.sec-023.21.json(Harling et al., 2005)* 88 (95% CI: 62, 96)
- Issued
- 2005
- Type
- document
- As printed
- (Harling et al., 2005)* 88 (95% CI: 62, 96)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.21 - provenance: extracted
- read from
references/10665-97885.sec-023.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
United States Close contacts 88 (95% CI: 63, 96) (Sartorius et al., 2005)
· extracted · source:references/10665-97885.sec-023.23.jsonUnited States Close contacts 88 (95% CI: 63, 96) (Sartorius et al., 2005)
- Issued
- 2005
- Type
- document
- As printed
- United States Close contacts 88 (95% CI: 63, 96) (Sartorius et al., 2005)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.23 - provenance: extracted
- read from
references/10665-97885.sec-023.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
United States Camp population 92 (95% CI: 83, 96) (Cohen et al., 2007)* 95 (95% CI: 93, 96)
· extracted · source:references/10665-97885.sec-023.25.jsonUnited States Camp population 92 (95% CI: 83, 96) (Cohen et al., 2007)* 95 (95% CI: 93, 96)
- Issued
- 2007
- Type
- document
- As printed
- United States Camp population 92 (95% CI: 83, 96) (Cohen et al., 2007)* 95 (95% CI: 93, 96)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.25 - provenance: extracted
- read from
references/10665-97885.sec-023.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Urabe Am 9 (Ong et al., 2005) 54 (95% CI: -16, 82)
· extracted · source:references/10665-97885.sec-023.26.jsonUrabe Am 9 (Ong et al., 2005) 54 (95% CI: -16, 82)
- Issued
- 2005
- Type
- document
- As printed
- Urabe Am 9 (Ong et al., 2005) 54 (95% CI: -16, 82)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.26 - provenance: extracted
- read from
references/10665-97885.sec-023.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Goncalves et al., 1998) 70 (95% CI: 25, 88)
· extracted · source:references/10665-97885.sec-023.27.json(Goncalves et al., 1998) 70 (95% CI: 25, 88)
- Issued
- 1998
- Type
- document
- As printed
- (Goncalves et al., 1998) 70 (95% CI: 25, 88)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.27 - provenance: extracted
- read from
references/10665-97885.sec-023.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Chamot et al., 1998) 73 (95% CI: 42, 88)
· extracted · source:references/10665-97885.sec-023.28.json(Chamot et al., 1998) 73 (95% CI: 42, 88)
- Issued
- 1998
- Type
- document
- As printed
- (Chamot et al., 1998) 73 (95% CI: 42, 88)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.28 - provenance: extracted
- read from
references/10665-97885.sec-023.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Toscani et al., 1996) 76 (95% CI: 36, 91)
· extracted · source:references/10665-97885.sec-023.29.json(Toscani et al., 1996) 76 (95% CI: 36, 91)
- Issued
- 1996
- Type
- document
- As printed
- (Toscani et al., 1996) 76 (95% CI: 36, 91)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.29 - provenance: extracted
- read from
references/10665-97885.sec-023.29.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Schlegel et al., 1999) 87 (95% CI: 76, 94)
· extracted · source:references/10665-97885.sec-023.30.json(Schlegel et al., 1999) 87 (95% CI: 76, 94)
- Issued
- 1999
- Type
- document
- As printed
- (Schlegel et al., 1999) 87 (95% CI: 76, 94)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.30 - provenance: extracted
- read from
references/10665-97885.sec-023.30.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Rubini (Pons et al., 2000) -340 (Ong et al., 2005) -55 (95% CI: -122, -9)
· extracted · source:references/10665-97885.sec-023.31.jsonRubini (Pons et al., 2000) -340 (Ong et al., 2005) -55 (95% CI: -122, -9)
- Issued
- 2005
- Type
- document
- As printed
- Rubini (Pons et al., 2000) -340 (Ong et al., 2005) -55 (95% CI: -122, -9)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.31 - provenance: extracted
- read from
references/10665-97885.sec-023.31.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Schlegel et al., 1999) -4 (95% CI: -218, 15)
· extracted · source:references/10665-97885.sec-023.32.json(Schlegel et al., 1999) -4 (95% CI: -218, 15)
- Issued
- 1999
- Type
- document
- As printed
- (Schlegel et al., 1999) -4 (95% CI: -218, 15)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.32 - provenance: extracted
- read from
references/10665-97885.sec-023.32.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Goncalves et al., 1998) 1 (95% CI: -108, 53)
· extracted · source:references/10665-97885.sec-023.33.json(Goncalves et al., 1998) 1 (95% CI: -108, 53)
- Issued
- 1998
- Type
- document
- As printed
- (Goncalves et al., 1998) 1 (95% CI: -108, 53)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.33 - provenance: extracted
- read from
references/10665-97885.sec-023.33.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Chamot et al., 1998) 6 (95% CI: -46, 40)
· extracted · source:references/10665-97885.sec-023.34.json(Chamot et al., 1998) 6 (95% CI: -46, 40)
- Issued
- 1998
- Type
- document
- As printed
- (Chamot et al., 1998) 6 (95% CI: -46, 40)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.34 - provenance: extracted
- read from
references/10665-97885.sec-023.34.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Toscani et al., 1996) 12 (95% CI: -102, 62)
· extracted · source:references/10665-97885.sec-023.35.json(Toscani et al., 1996) 12 (95% CI: -102, 62)
- Issued
- 1996
- Type
- document
- As printed
- (Toscani et al., 1996) 12 (95% CI: -102, 62)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.35 - provenance: extracted
- read from
references/10665-97885.sec-023.35.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Pons et al., 2000) 40 (95% CI: -66, 78)
· extracted · source:references/10665-97885.sec-023.36.json(Pons et al., 2000) 40 (95% CI: -66, 78)
- Issued
- 2000
- Type
- document
- As printed
- (Pons et al., 2000) 40 (95% CI: -66, 78)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.36 - provenance: extracted
- read from
references/10665-97885.sec-023.36.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
The immunological basis for immunization series - Module 16: Mumps (Richard et al., 2003)
· extracted · source:references/10665-97885.sec-023.37.jsonThe immunological basis for immunization series - Module 16: Mumps (Richard et al., 2003)
- Issued
- 2003
- Type
- document
- As printed
- The immunological basis for immunization series - Module 16: Mumps (Richard et al., 2003)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.37 - provenance: extracted
- read from
references/10665-97885.sec-023.37.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
· extracted · source:references/10665-97885.sec-023.38.json(young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
- Issued
- 1995
- Type
- document
- As printed
- (young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.38 - provenance: extracted
- read from
references/10665-97885.sec-023.38.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Leningrad-Zagreb (Beck et al., 1989)
· extracted · source:references/10665-97885.sec-023.39.jsonLeningrad-Zagreb (Beck et al., 1989)
- Issued
- 1989
- Type
- document
- As printed
- Leningrad-Zagreb (Beck et al., 1989)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.39 - provenance: extracted
- read from
references/10665-97885.sec-023.39.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Yugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
· extracted · source:references/10665-97885.sec-023.40.jsonYugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
- Issued
- 1965
- Type
- document
- As printed
- Yugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.40 - provenance: extracted
- read from
references/10665-97885.sec-023.40.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
S79 (Fu et al., 2008) 86 (95% CI: 77, 92)
· extracted · source:references/10665-97885.sec-023.41.jsonS79 (Fu et al., 2008) 86 (95% CI: 77, 92)
- Issued
- 2008
- Type
- document
- As printed
- S79 (Fu et al., 2008) 86 (95% CI: 77, 92)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.41 - provenance: extracted
- read from
references/10665-97885.sec-023.41.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Fu et al., 2009) 83 (95% CI: 68, 91)
· extracted · source:references/10665-97885.sec-023.42.json(Fu et al., 2009) 83 (95% CI: 68, 91)
- Issued
- 2009
- Type
- document
- As printed
- (Fu et al., 2009) 83 (95% CI: 68, 91)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.42 - provenance: extracted
- read from
references/10665-97885.sec-023.42.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Sofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
· extracted · source:references/10665-97885.sec-023.43.jsonSofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
- Issued
- 1994
- Type
- document
- As printed
- Sofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.43 - provenance: extracted
- read from
references/10665-97885.sec-023.43.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Although five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
· extracted · source:references/10665-97885.sec-023.45.jsonAlthough five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
- Issued
- 2008
- Type
- document
- As printed
- Although five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.45 - provenance: extracted
- read from
references/10665-97885.sec-023.45.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
A number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
· extracted · source:references/10665-97885.sec-023.46.jsonA number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
- Issued
- 2007
- Type
- document
- As printed
- A number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023.46 - provenance: extracted
- read from
references/10665-97885.sec-023.46.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
· extracted · source:references/10665-97885.sec-023-2.2.json(young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
- Issued
- 1995
- Type
- document
- As printed
- (young children) 30 (95% CI: -30, 60) (Paccaud et al., 1995) 50 (95% CI: -19, 81)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.2 - provenance: extracted
- read from
references/10665-97885.sec-023-2.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Leningrad-Zagreb (Beck et al., 1989)
· extracted · source:references/10665-97885.sec-023-2.3.jsonLeningrad-Zagreb (Beck et al., 1989)
- Issued
- 1989
- Type
- document
- As printed
- Leningrad-Zagreb (Beck et al., 1989)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.3 - provenance: extracted
- read from
references/10665-97885.sec-023-2.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Yugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
· extracted · source:references/10665-97885.sec-023-2.4.jsonYugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
- Issued
- 1965
- Type
- document
- As printed
- Yugoslavia Pre-school 97-100 Leningrad-3 (Smorodintsev et al., 1965) 94 (95% CI: 76, 98)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.4 - provenance: extracted
- read from
references/10665-97885.sec-023-2.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
S79 (Fu et al., 2008) 86 (95% CI: 77, 92)
· extracted · source:references/10665-97885.sec-023-2.5.jsonS79 (Fu et al., 2008) 86 (95% CI: 77, 92)
- Issued
- 2008
- Type
- document
- As printed
- S79 (Fu et al., 2008) 86 (95% CI: 77, 92)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.5 - provenance: extracted
- read from
references/10665-97885.sec-023-2.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
(Fu et al., 2009) 83 (95% CI: 68, 91)
· extracted · source:references/10665-97885.sec-023-2.6.json(Fu et al., 2009) 83 (95% CI: 68, 91)
- Issued
- 2009
- Type
- document
- As printed
- (Fu et al., 2009) 83 (95% CI: 68, 91)
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.6 - provenance: extracted
- read from
references/10665-97885.sec-023-2.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Sofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
· extracted · source:references/10665-97885.sec-023-2.7.jsonSofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
- Issued
- 1994
- Type
- document
- As printed
- Sofia 6 (Odisseev & Gacheva, 1994) Bulgaria Contacts * Some of the study population may have received mumps vaccine containing RIT 4385 strain.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.7 - provenance: extracted
- read from
references/10665-97885.sec-023-2.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Although five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
· extracted · source:references/10665-97885.sec-023-2.9.jsonAlthough five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
- Issued
- 2008
- Type
- document
- As printed
- Although five of the six studies had higher vaccine effectiveness for two doses compared to one dose, only one study reached statistical significance, and this was probably due to the large sample size (Cohen et al., 2007). Despite relatively high two-dose vaccine effectiveness, high two-dose vaccine coverage may not be sufficient to prevent all outbreaks (Cortese et al., 2008; Dayan & Rubin, 2008).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.9 - provenance: extracted
- read from
references/10665-97885.sec-023-2.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
A number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
· extracted · source:references/10665-97885.sec-023-2.10.jsonA number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
- Issued
- 2007
- Type
- document
- As printed
- A number of studies documented increased risk of developing mumps with increasing time after vaccination (Vandermeulen et al., 2004; Cortese et al., 2008; Castilla et al., 2009), and data from the United Kingdom indicates vaccine effectiveness may decrease with age, which probably also reflects increasing time from vaccination (Cohen et al., 2007).
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-023-2.10 - provenance: extracted
- read from
references/10665-97885.sec-023-2.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-023-52-vaccine-effectiveness.md
-
Afzal MA et al. (1993). The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. The Journal of General Virology, 74 (Pt. 5):917–920.
· extracted · source:references/10665-97885.sec-024.1.jsonAfzal MA et al. (1993). The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. The Journal of General Virology, 74 (Pt. 5):917–920.
- Issued
- 1993
- Type
- document
- As printed
- Afzal MA et al. (1993). The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. The Journal of General Virology, 74 (Pt. 5):917–920.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.1 - provenance: extracted
- read from
references/10665-97885.sec-024.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Al-Mazrou Y et al. (2002). Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. Journal of Tropical Pediatrics, 48(6):354–358.
· extracted · source:references/10665-97885.sec-024.2.jsonAl-Mazrou Y et al. (2002). Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. Journal of Tropical Pediatrics, 48(6):354–358.
- Issued
- 2002
- Type
- document
- As printed
- Al-Mazrou Y et al. (2002). Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. Journal of Tropical Pediatrics, 48(6):354–358.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.2 - provenance: extracted
- read from
references/10665-97885.sec-024.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Arday DR et al. (1989). Mumps in the US Army 1980–86: should recruits be immunized? American Journal of Public Health, 79(4):471–474.
· extracted · source:references/10665-97885.sec-024.3.jsonArday DR et al. (1989). Mumps in the US Army 1980–86: should recruits be immunized? American Journal of Public Health, 79(4):471–474.
- Issued
- 1980
- Type
- document
- As printed
- Arday DR et al. (1989). Mumps in the US Army 1980–86: should recruits be immunized? American Journal of Public Health, 79(4):471–474.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.3 - provenance: extracted
- read from
references/10665-97885.sec-024.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Arruda WO, Kondageski C (2001). Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998. Revista do Instituto de Medicina Tropical de São Paulo, 43(5):301–302.
· extracted · source:references/10665-97885.sec-024.4.jsonArruda WO, Kondageski C (2001). Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998. Revista do Instituto de Medicina Tropical de São Paulo, 43(5):301–302.
- Issued
- 1998
- Type
- document
- As printed
- Arruda WO, Kondageski C (2001). Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Parana, Brazil, 1998. Revista do Instituto de Medicina Tropical de São Paulo, 43(5):301–302.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.4 - provenance: extracted
- read from
references/10665-97885.sec-024.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Association for the Study of Infectious Diseases (1974). A retrospective survey of the complications of mumps. The Journal of the Royal College of General Practitioners, 24(145):552–556.
· extracted · source:references/10665-97885.sec-024.5.jsonAssociation for the Study of Infectious Diseases (1974). A retrospective survey of the complications of mumps. The Journal of the Royal College of General Practitioners, 24(145):552–556.
- Issued
- 1974
- Type
- document
- As printed
- Association for the Study of Infectious Diseases (1974). A retrospective survey of the complications of mumps. The Journal of the Royal College of General Practitioners, 24(145):552–556.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.5 - provenance: extracted
- read from
references/10665-97885.sec-024.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Atrasheuskaya AV et al. (2006). Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Vaccine, 24(10):1530–1536.
· extracted · source:references/10665-97885.sec-024.6.jsonAtrasheuskaya AV et al. (2006). Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Vaccine, 24(10):1530–1536.
- Issued
- 2006
- Type
- document
- As printed
- Atrasheuskaya AV et al. (2006). Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Vaccine, 24(10):1530–1536.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.6 - provenance: extracted
- read from
references/10665-97885.sec-024.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Azimi PH et al. (1969). Mumps meningoencephalitis in children. JAMA : The Journal of the American Medical Association, 207(3):509–512.
· extracted · source:references/10665-97885.sec-024.7.jsonAzimi PH et al. (1969). Mumps meningoencephalitis in children. JAMA : The Journal of the American Medical Association, 207(3):509–512.
- Issued
- 1969
- Type
- document
- As printed
- Azimi PH et al. (1969). Mumps meningoencephalitis in children. JAMA : The Journal of the American Medical Association, 207(3):509–512.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.7 - provenance: extracted
- read from
references/10665-97885.sec-024.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Bang HO, Bang J (1943). Involvement of the central nervous system in mumps.
· extracted · source:references/10665-97885.sec-024.8.jsonBang HO, Bang J (1943). Involvement of the central nervous system in mumps.
- Issued
- 1943
- Type
- document
- As printed
- Bang HO, Bang J (1943). Involvement of the central nervous system in mumps.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.8 - provenance: extracted
- read from
references/10665-97885.sec-024.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Acta medica scandinavica, 113:487–505. Beard CM et al. (1977). The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clinic Proceedings. Mayo Clinic, 52(1):3–7.
· extracted · source:references/10665-97885.sec-024.9.jsonActa medica scandinavica, 113:487–505. Beard CM et al. (1977). The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clinic Proceedings. Mayo Clinic, 52(1):3–7.
- Issued
- 1974
- Type
- document
- As printed
- Acta medica scandinavica, 113:487–505. Beard CM et al. (1977). The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clinic Proceedings. Mayo Clinic, 52(1):3–7.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.9 - provenance: extracted
- read from
references/10665-97885.sec-024.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Beck M et al. (1989). Mumps vaccine L-Zagreb, prepared in chick fibroblasts.
· extracted · source:references/10665-97885.sec-024.10.jsonBeck M et al. (1989). Mumps vaccine L-Zagreb, prepared in chick fibroblasts.
- Issued
- 1989
- Type
- document
- As printed
- Beck M et al. (1989). Mumps vaccine L-Zagreb, prepared in chick fibroblasts.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.10 - provenance: extracted
- read from
references/10665-97885.sec-024.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
I. Production and field trials. Journal of Biological Standardization, 17(1):85–90. Benito RJ et al. (1987). Persistence of specific IgM antibodies after natural mumps infection. The Journal of Infectious Diseases, 155(1):156–157.
· extracted · source:references/10665-97885.sec-024.11.jsonI. Production and field trials. Journal of Biological Standardization, 17(1):85–90. Benito RJ et al. (1987). Persistence of specific IgM antibodies after natural mumps infection. The Journal of Infectious Diseases, 155(1):156–157.
- Issued
- 1987
- Type
- document
- As printed
- I. Production and field trials. Journal of Biological Standardization, 17(1):85–90. Benito RJ et al. (1987). Persistence of specific IgM antibodies after natural mumps infection. The Journal of Infectious Diseases, 155(1):156–157.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.11 - provenance: extracted
- read from
references/10665-97885.sec-024.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Berger R et al. (1988). Interference between strains in live virus vaccines. I: Combined vaccination with measles, mumps and rubella vaccine. Journal of Biological Standardization, 16(4):269–273.
· extracted · source:references/10665-97885.sec-024.12.jsonBerger R et al. (1988). Interference between strains in live virus vaccines. I: Combined vaccination with measles, mumps and rubella vaccine. Journal of Biological Standardization, 16(4):269–273.
- Issued
- 1988
- Type
- document
- As printed
- Berger R et al. (1988). Interference between strains in live virus vaccines. I: Combined vaccination with measles, mumps and rubella vaccine. Journal of Biological Standardization, 16(4):269–273.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.12 - provenance: extracted
- read from
references/10665-97885.sec-024.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Bernstein HH et al. (2007). Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics, 119(6):e1299–e1305.
· extracted · source:references/10665-97885.sec-024.13.jsonBernstein HH et al. (2007). Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics, 119(6):e1299–e1305.
- Issued
- 2007
- Type
- document
- As printed
- Bernstein HH et al. (2007). Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics, 119(6):e1299–e1305.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.13 - provenance: extracted
- read from
references/10665-97885.sec-024.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
Bitnun S et al. (1986). Acute bilateral total deafness complicating mumps.
· extracted · source:references/10665-97885.sec-024.14.jsonBitnun S et al. (1986). Acute bilateral total deafness complicating mumps.
- Issued
- 1986
- Type
- document
- As printed
- Bitnun S et al. (1986). Acute bilateral total deafness complicating mumps.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.14 - provenance: extracted
- read from
references/10665-97885.sec-024.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md
-
The Journal of Laryngology and Otology, 100(8):943–945.
· extracted · source:references/10665-97885.sec-024.15.jsonThe Journal of Laryngology and Otology, 100(8):943–945.
- Type
- document
- As printed
- The Journal of Laryngology and Otology, 100(8):943–945.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-97885.sec-024.15 - provenance: extracted
- read from
references/10665-97885.sec-024.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-97885/sections/sec-024-references.md